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The purpose of this study was to test the hypothesis that diabetes aggravates periodontal destruction induced by Aggregatibacter
actinomycetemcomitans infection. Thirty-eight diabetic and 33 normal rats were inoculated with A. actinomycetemcomitans and
euthanized at baseline and at 4, 5, and 6 weeks after inoculation. Bone loss and the infiltration of polymorphonuclear leukocytes
(PMNs) in gingival epithelium were measured in hematoxylin-eosin-stained sections. The induction of tumor necrosis factor
alpha (TNF-) was evaluated by immunohistochemistry and of apoptotic cells by a TUNEL (terminal deoxynucleotidyltrans-
ferase-mediated dUTP-biotin nick end labeling) assay. After A. actinomycetemcomitans infection, the bone loss in diabetic rats
was 1.7-fold and the PMN infiltration 1.6-fold higher than in normoglycemic rats (P < 0.05). The induction of TNF- was 1.5-
fold higher and of apoptotic cells was up to 3-fold higher in diabetic versus normoglycemic rats (P < 0.05). Treatment with a
caspase-3 inhibitor significantly blocked noninflammatory cell apoptosis induced by A. actinomycetemcomitans infection in
gingival epithelium and connective tissue (P < 0.05). These results provide new insight into how diabetes aggravates A. actino-
mycetemcomitans-induced periodontal destruction in rats by significantly increasing the inflammatory response, leading to in-
creased bone loss and enhancing apoptosis of gingival epithelial and connective tissue cells through a caspase-3-dependent
mechanism. Antibiotics had a more pronounced effect on many of these parameters in diabetic than in normoglycemic rats, sug-
gesting a deficiency in the capacity of diabetic animals to resist infection.
Periodontitis is one of the most prevalent infectious diseasesworldwide. It is characterized by loss of supporting connective
tissue and alveolar bone around the teeth (36). Although triggered
by a bacterial infection, the destruction of periodontal tissue is
caused by the inflammatory response to pathogenic bacteria. Im-
mune mediators such as interleukin-1 (IL-1), tumor necrosis fac-
tor alpha (TNF-), IL-6, and RANKL have been found to be abun-
dantly expressed in humans with periodontal disease, and
increased levels have been shown in the crevicular fluid from pa-
tients with periodontitis (4, 13, 32). Animal studies have estab-
lished cause-and-effect relationships between these cytokines and
periodontal breakdown (13, 24).
There are several types of periodontal diseases ranging from
chronic periodontitis that affects adults to a form of aggressive
periodontitis that primarily affects adolescents, localized aggres-
sive periodontitis (LAgP). LAgP is characterized by severe and
rapid destruction of the supporting apparatus of the teeth, which
may lead to tooth loss early in life (3). Aggregatibacter actinomyce-
temcomitans is commonly linked to LAgP (3, 16), and studies have
shown that periodontal treatment leads to a reduction in its levels
(5, 31). The presence of A. actinomycetemcomitans in periodontal
pockets has also been considered indicative of future disease pro-
gression (9, 16). A. actinomycetemcomitans has virulence factors,
such as leukotoxin and cytolethal distending toxin (CDT), that
may contribute to its capacity to induce rapid tissue destruction by
promoting apoptosis of a number of host cell types (20).
A rat model has been developed to study the pathogenic mech-
anisms of A. actinomycetemcomitans-induced periodontal tissue
destruction (8, 28, 38, 39). This model is characterized by infecting
the animals with a rough strain of A. actinomycetemcomitans that
adheres to the oral epithelium and teeth (7). Although it may not
mimic the specific form of periodontal disease found in localized
aggressive periodontitis in humans, this model has provided in-
sight into the colonization of the oral cavity by this bacterium and
inflammation-induced periodontitis (28). However, relatively lit-
tle is known about the local changes that are induced by this bac-
terium in vivo.
Periodontal disease is triggered by bacterial infection, but the
local inflammatory response has been shown to mediate the actual
destruction of periodontal tissue. This response can be modulated
by systemic conditions such as diabetes. Diabetes has been iden-
tified as one of the important risk factors for periodontitis, in-
creasing both its prevalence and severity (26, 27, 40). One mech-
anism through which diabetes increases periodontal tissue loss
and other diabetic complications is by exacerbating the inflamma-
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tory response to periodontal pathogens through increased oxida-
tive stress, advanced glycation end products, and expression of
cytokines such as TNF- (12, 25, 33, 37).
Apoptosis is thought to contribute to periodontal disease pro-
gression. It has been suggested that apoptosis of epithelial cells
may contribute to the loss of epithelial barrier function (6). More-
over, loss of gingival fibroblasts has been shown to be one of the
largest cellular changes that occurs with periodontal disease pro-
gression and may be associated with a loss of connective tissue
attachment (29, 43). Infection by A. actinomycetemcomitans has
been shown to induce apoptosis in vitro (21–23). However, rela-
tively little is known about how it induces apoptosis in vivo and
how a systemic condition such as diabetes affects A. actinomyce-
temcomitans-induced apoptosis and periodontal tissue destruc-
tion. The experiments described here address these issues using
diabetic and matched normoglycemic rats, which are natural
hosts of A. actinomycetemcomitans. The results indicate that the
effect of A. actinomycetemcomitans infection on bone loss, TNF-
expression, and apoptosis of epithelial cells and nonleukocytic
gingival connective tissue cells is aggravated by diabetes. More-
over, we demonstrate that apoptosis is induced by a caspase-3-
dependent mechanism.
MATERIALS AND METHODS
Animals. Goto-Kakizaki (GK) and normoglycemic control matched
Wistar rats (5 to 10 weeks old) weighing 150 to 250 g were purchased from
Charles River Laboratories (Wilmington, MA). The GK rat is a nonobese
Wistar substrain that develops type 2 diabetes mellitus at age approxi-
mately 8 weeks. Rats were considered to be diabetic when glycated hemo-
globin (HbAlc) levels exceeded 7.0%. During the experiments, the HbAlc
level in GK rats was typically 7.0 to 10.5%. All normoglycemic rats had
HbAlc levels that ranged from 4.3 to 4.8%. All animal procedures were
approved by the Institutional Animal Care and Use Committee.
A. actinomycetemcomitans inoculation. Both diabetic (GK) and nor-
mal (Wistar) rats were inoculated with A. actinomycetemcomitans as pre-
viously described (39). To depress the “natural” resident flora, rats re-
ceived in their water a daily dose of kanamycin (20 mg) and ampicillin (20
mg) for 4 days. During the last 2 days of antibiotic treatment, the oral
cavities of the rats were swabbed with a 0.12% chlorhexidine gluconate
rinse (Peridex; Procter and Gamble, Cincinnati, OH). After a subsequent
period of 3 days without antibiotic treatment, the rats were divided into
six groups of approximately seven rats each. The adherent A. actinomyce-
temcomitans strain, Columbia University A. actinomycetemcomitans clin-
ical isolate 1000 (CU1000NRif), was incubated in A. actinomycetemcomi-
tans growth medium with 35 mg of rifampin (Sigma-Aldrich, St. Louis,
MO)/ml for 2 days. Adherent cells in culture dishes were scraped into a
solution of phosphate-buffered saline (PBS) plus 3% sucrose, and minor
adjustment was made by the addition of buffer to obtain 108 cells/ml
(optical density at 560 nm  0.80). After fasting for 3 h, rats received 108
A. actinomycetemcomitans cells in 1 g of powdered food supplemented
with 3% sucrose. This protocol was followed for 4 days and was repeated
the following week for a total of eight A. actinomycetemcomitans inocula-
tions in food (39). During the first 4 days of the feeding, the rats also
received 108 A. actinomycetemcomitans in PBS by oral gavage. After 1 h,
the inoculated food was removed and replaced with regular powdered
food. Rats were euthanized 4, 5, and 6 weeks after the inoculation period
was completed. Baseline animals did not receive A. actinomycetemcomi-
tans in their food and were not inoculated with A. actinomycetemcomitans
but did receive powered food supplemented with 3% sucrose under the
same conditions as the experimental rats.
Treatment with antibiotics and caspase-3 inhibitor. At 4 weeks after
A. actinomycetemcomitans inoculation, two groups of rats received in their
water a daily dose of kanamycin (20 mg) and ampicillin (20 mg) for 4 days
with the intention to reduce the infection. Concomitantly, the oral cavities
of the rats were swabbed with a 0.12% chlorhexidine gluconate rinse
(Peridex).
Caspase-3 inhibitor (Z-DEVD-FMK; SM Biochemicals, Anaheim,
CA) was administered by intraperitoneal injection (1.5 mg/kg). Control
animals were injected with the same volume of vehicle (2% dimethyl
sulfoxide; MP Biomedicals, Solon, OH). The caspase-3 inhibitor was ad-
ministrated 1 week before euthanasia, and it was injected daily until the
animals were euthanized.
Sampling of total anaerobic bacteria (CFU) and detection of A. ac-
tinomycetemcomitans by PCR. Two microbial samples were collected:
one after the inoculation of A. actinomycetemcomitans and the other at the
time of euthanasia. The rats were anesthetized, and their oral microflora
was sampled using a cotton tip swab for soft tissue sampling and a tooth-
pick (Johnson & Johnson, Piscataway, NJ) for hard tissue sampling. Both
samples were combined in tubes containing 1 ml of PBS. Serial 10-fold
dilutions were made and plated on Trypticase soy agar with 5% sheep
blood (BD Biosciences, San Jose, CA) for total anaerobe counts. Trypti-
case soy agar plates were incubated in an anaerobic atmosphere at 37°C for
7 days to obtain total bacterial counts. To detect whether A. actinomyce-
temcomitans was present in the samples, DNA was prepared directly from
the collected oral samples with a DNA extraction kit (Qiagen, Valencia,
CA) and subjected to PCR analysis using forward and reverse primers
(5=-GGAATTCCTAGGTATTGCGAAACAATTTGATC-3= and 5=-GGA
ATTCCTGAAATTAAGCTGGTAATC-3=, respectively), which amplified
a 262-bp PCR product from the A. actinomycetemcomitans leukotoxin
gene as previously described (10).
Level of antibody to A. actinomycetemcomitans. IgG antibody reac-
tive with A. actinomycetemcomitans was assessed by enzyme-linked im-
munosorbent assay (ELISA). Blood was collected by cardiac puncture and
serum was obtained and stored at 20°C. An A. actinomycetemcomitans
lysate was prepared and used to coat the wells of microtiter dishes (Nunc-
ImmunoPlate with a Maxi Sorp surface; Thermo Fisher Scientific, Roch-
ester, NY). A standard curve was generated using purified rat IgG (Sigma-
Aldrich) in carbonate-bicarbonate buffer (pH 9.6; Sigma-Aldrich). Rat
serum diluted 1/5 and 1/10 in blocking buffer was added to the wells
coated with A. actinomycetemcomitans pellet lysate. The serum dilutions
were added in duplicate wells, washed, incubated with rabbit anti-rat
IgG-Fc conjugated to alkaline phosphatase (Bethyl Laboratories, Mont-
gomery, TX), and quantified with p-nitrophenyl phosphate substrate
(Sigma-Aldrich). Absorbance was read on a microplate reader at 405 nm.
Histomorphometric analysis of hematoxylin-eosin-stained sec-
tions. Right maxillas were fixed in 4% paraformaldehyde at 4°C for 48 h
and decalcified in 10% EDTA (pH 7.0) for 12 weeks. Paraffin-embedded
sagittal sections were prepared at a thickness of 5 m. The mid-interprox-
imal region between first and second molars was examined in each spec-
imen and was established by being sectioned to a level where the root canal
systems in adjacent teeth were visible. Two randomly chosen sections of
each interproximal area were examined at 200 magnification. All data
were analyzed by a blinded examiner who did not know the group to
which an animal belonged. Bone loss was measured as the distance be-
tween the cemento-enamel junction (CEJ) and the highest peak of the
interproximal bone. The number of polymorphonuclear (PMNs) leuko-
cytes was counted in the gingival epithelium at 600 magnification. The
identification of these cells was confirmed by an experienced examiner.
Histomorphometric analysis of TNF- immunohistochemistry-
stained sections. To evaluate the number of cells expressing TNF-, sec-
tions were stained by immunohistochemistry with an antibody against
TNF- (IHC World, Woodstock, MD). The number of positive cells was
evaluated 1 mm down from the level of bone crest apically in an area of
periodontal ligament between the first and second molars. Cell counts
were obtained by one examiner and confirmed by a second independent
examiner with similar results. The numbers of positive cells in epithelium
and gingival connective tissue were scored based on the following scale: 0,
no positive cells; 1, three to four positive cells per field with weak immu-
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nostaining; 2, four to ten positive cells per field with strong immunostain-
ing; and 3, more than ten positive cells per field with strong immunostain-
ing. Sections were examined at 600 magnification.
Detection of apoptotic cells. Apoptotic cells were detected by an in
situ TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-bio-
tin nick end labeling) assay (DeadEnd fluorometric TUNEL system kit;
Promega, Madison, WI) according to the manufacturer’s instructions.
This kit detects double-strand breaks in genomic DNA and identifies most
stages of apoptosis. The fluorescein-12-dUTP-labeled DNA was then
visualized directly by fluorescence microscopy. Additional counts were
made to specifically avoid counting apoptotic leukocytes. This was ac-
complished by using the TUNEL assay, followed by immunofluorescence
with an anti-CD18 antibody (Novus Biological, Littleton, CO). The num-
ber of nonleukocytic apoptotic cells (TUNEL CD18) was counted at
200 magnification with an immunofluorescence microscope using NIS
Elements software (Nikon, Melville, NY) in epithelium or connective tis-
sue above the alveolar bone crest. Cells counts were obtained by one
examiner and confirmed by a second independent examiner with similar
results.
Systemic leukocyte analysis. Rat lymph leukocytes were isolated and
analyzed as previously described (28). Single-cell suspensions were ob-
tained from the submandibular and cervical lymph nodes. Lymphocyte
populations were isolated by Ficoll-Hypaque density gradient centrifuga-
tion. Flow cytometry was conducted using anti-CD32 (clone D34-485)
for blocking FcII receptors, phycoerythrin (PE)-conjugated anti-CD4
(clone OX-38), fluorescein isothiocyanate (FITC)-conjugated anti-CD3
(clone G4.18; BD Biosciences); FITC-labeled anti-FoxP3 (clone FJK-16S),
and PE-conjugated anti-CD25 (clone OX39) from eBioscience (San Di-
ego, CA), and anti-IA (clone 14-4-4S) from the American Type Culture
Collection (Manassas, VA). Blood was analyzed by HemaTrue hematol-
ogy analyzer (Heska, Loveland, CO). The total numbers of white blood
cells, the numbers of lymphocytes, monocytes, and granulocytes, and the
percentages of lymphocytes, monocytes, and granulocytes were analyzed.
Statistical analysis. Differences between two groups such as diabetic
and normal rats were determined by using the Student t test and between
time points within a group by one-way analysis of variance except for the
evaluation of TNF-. Differences in TNF- values were determined by
nonparametric analysis with Mann-Whitney U test. Significance levels
were set at 5%.
RESULTS
Induction of periodontal disease. At baseline, the antibody titer
level in diabetic rats was low and increased after A. actinomycetem-
comitans infection so that at 6 weeks it was 32-fold higher than at
baseline (P  0.01) (Fig. 1A). Moreover, for all A. actinomycetem-
comitans infected diabetic rats, the antibody titers were 18-fold
higher than for the noninfected animals (P  0.01) (Fig. 1B). Also,
after infection diabetic the animals had antibody titers level that
were 2.3-fold higher than normoglycemic infected animals (P 
0.05) (Fig. 1B). Diabetic rats also showed a significant decrease in
antibody titer level after antibiotic treatment (P  0.05) (Fig. 1C).
The impact of A. actinomycetemcomitans infection on total an-
aerobic bacteria levels in noninfected normoglycemic and diabetic
rats, as well as infected diabetic rats, was also examined. Despite a
trend toward increased levels of anaerobic bacteria in infected
diabetic rats compared to normoglycemic rats, the differences
were not significant (see Table S1 in the supplemental material).
Similarly the percentage of rats exposed to A. actinomycetemcomi-
tans that had detectable infection was not higher between the nor-
moglycemic and diabetic groups (see Table S2 in the supplemental
material).
A number of parameters was evaluated to examine the impact
of A. actinomycetemcomitans infection on the systemic leukocyte
FIG 1 Diabetes increases the antibody titer to A. actinomycetemcomitans in
infected rats. Diabetic and normal rats were infected orally with A. actinomy-
cetemcomitans, and antibody (IgG) reactive with A. actinomycetemcomitans
was assessed by ELISA. At 4 weeks postinfection, one group of rats was treated
with antibiotics or equivalent vehicle alone. Rats were euthanized at baseline
and at 4, 5, and 6 weeks after A. actinomycetemcomitans inoculation was com-
pleted. (A) Antibody titer levels in diabetic rats over time. (B) Antibody titer in
noninfected (baseline) and infected (4 to 6 weeks) normoglycemic and dia-
betic rats. (C) Effect of antibiotic treatment on antibody titer in normoglyce-
mic and diabetic rats. Each value in panels A, B, and C is the mean of five to
seven rats 	 the standard error of the mean (SEM). *, significant difference
between diabetic and normal rats (P  0.05); , significant difference between
diabetic rats in different groups (P  0.05).
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populations in diabetic animals. After A. actinomycetemcomitans
infection there was no change in A. actinomycetemcomitans-in-
fected rats compared to uninfected rats of major histocompatibil-
ity complex (MHC) class II-positive cells, T cells, B cells, or Treg
cells for either normoglycemic or diabetic rats (Tables 1 and 2).
However, there was a slight reduction in the percentage of lym-
phocytes in the peripheral circulation of infected diabetic rats
compared to infected normoglycemic rats and a 1.5-fold increase
in the percentage of granulocytes in infected diabetic rats com-
pared to infected normoglycemic rats (P  0.05) (Table 2).
Bone loss was induced in the diabetic rats, as evidenced by an
increase in the distance from the CEJ to the alveolar bone crest
after 5 weeks (P  0.05) (Fig. 2A and see Fig. S1 in the supplemen-
tal material). In A. actinomycetemcomitans-infected diabetic ani-
mals there was a 1.8-fold increase in bone loss compared to non-
infected diabetic rats at baseline. The bone loss was 1.7-fold higher
in the infected diabetic rats compared to infected normoglycemic
rats (P  0.05) (Fig. 2B). Antibiotic treatment significantly de-
creased the bone loss in the diabetic rats (P  0.05) (Fig. 2C).
PMN infiltration. The formation of a PMN infiltrate in gingi-
val epithelium was assessed (see Fig. S2 in the supplemental ma-
terial). PMNs increased 7-fold (P  0.05) 4 weeks after A. actino-
mycetemcomitans inoculation in diabetic rats (Fig. 3A). Both
FIG 2 Diabetes increases bone loss in A. actinomycetemcomitans-infected rats.
The distance between the CEJ and the alveolar bone crest was measured. (A)
CEJ-to-bone distance in diabetic rats. (B) CEJ-to-bone distance in noninfected
(baseline) and infected (4 to 6 weeks) normoglycemic and diabetic rats. (C)
Effect of antibiotic treatment on CEJ-to-bone distance in normoglycemic and
diabetic rats. Each value is the mean of five to seven rats 	 the SEM. *, signif-
icant difference between diabetic and normal rats (P  0.05); , significant
difference between diabetic rats in different groups (P  0.05).




Normal rats Diabetic rats
Noninfected Infected Noninfected Infected
MHC II 55.9 	 11.7 44.1 	 14.8 38.3 	 6.8* 37.0 	 12.0
CD4 31.5.1 	 11.4 32.4 	 13.0 42.1 	 9.3 42.7 	 13.9
CD8 24.6 	 6.9 35.2 	 10.7 29.6 	 9.4 31.4 	 8.9
CD25 5.2 	 0.9 6.7 	 2.8 5.4 	 0.8 7.9 	 2.4
FoxP3 4.3 	 0.8 5.3 	 3.1 7.0 	 3.4 7.2 	 2.4
a Lymphocyte populations from draining cervical and submandibular lymph nodes
were analyzed as described in Materials and Methods. The rats described in Fig. 1 were
examined for lymphocyte populations according to infection status. Each value is the
mean of five to seven rats. *, P  0.05, compared to normal rats.





Noninfected Infected Noninfected Infected
No. (103 UI/ml)
WBC 7.9 	 2.9 7.8 	 4.7 6.9 	 3.2 8.0 	 4.0
Lymphocytes 6.2 	 2.5 5.8 	 3.3 4.4 	 1.0 5.2 	 2.8
Monocytes 0.4 	 0.1 0.3 	 0.2 0.4 	 0.3 0.4 	 0.2
Granulocytes 1.3 	 0.5 1.7 	 1.5 2.2 	 2.0 2.3 	 1.4
Amt (%)
Lymphocytes 77.0 	 5.5 76.0 	 10.5 69.0 	 13.8 65.6 	 13.5*
Monocytes 4.8 	 1.0 3.5 	 1.2 4.8 	 1.4 4.5 	 1.8
Granulocytes 18.1 	 4.6 20.6 	 9.9 26.2 	 12.5 30.0 	 13.4*
a Leukocytic cells from peripheral blood were analyzed as described in Materials and
Methods. The rats described in Fig. 1 were examined for leukocytic cells according to
infection status. Each value is the mean of five to seven rats. *, P 0.05, compared to
normal rats. WBC, white blood cells.
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normal and diabetic noninfected rats had similar levels of PMNs.
After A. actinomycetemcomitans infection PMN numbers in-
creased 3.4-fold in normal rats, while it increased 5.3-fold in dia-
betic rats (P  0.05) (Fig. 3B). The greater increase in PMNs in
infected diabetic rats, compared to infected normal rats, is con-
sistent with the significant increase (P  0.05) in blood gran-
ulocytes in infected diabetic rats. Antibiotic treatment signifi-
cantly reduced the PMN infiltration in the diabetic rats (P 
0.05) (Fig. 3C).
TNF-. TNF- was measured in the gingival epithelium and
connective tissue. In the epithelium, the TNF- values of diabetic
rats were significantly higher in animals exposed to A. actinomy-
cetemcomitans inoculation compared to noninfected diabetic rats
(P  0.05) and significantly higher than in infected normoglyce-
mic rats (P  0.05) (Fig. 4B and see Fig. S3 in the supplemental
material). Antibiotic treatment resulted in a significant decrease in
TNF- expression in the epithelium of diabetic rats (P  0.05) but
had no effect in the normoglycemic group (Fig. 4C).
TNF- was also measured in the gingival connective tissue. It
significantly increased in diabetic rats 5 weeks after A. actinomy-
cetemcomitans infection (P  0.05) (Fig. 5A) and was substantially
higher than values found in infected normoglycemic rats (P 
0.05) (Fig. 5B). When rats were treated with antibiotic, there were
no differences in TNF- levels in the connective tissues of diabetic
and normal rats (P 
 0.05) (Fig. 5C).
FIG 3 Diabetes increases the number of PMNs of A. actinomycetemcomitans-
infected rats. The number of PMNs infiltrating the gingival epithelium was
measured. (A) PMN infiltration in diabetic rats over time. (B) PMNs in non-
infected (baseline) and infected (4 to 6 weeks) normoglycemic and diabetic
rats. (C) Effect of antibiotic treatment on PMN infiltration in normoglycemic
and diabetic rats. Each value in panels A, B, and C is the mean of five to seven
rats 	 the SEM. *, significant difference between diabetic and normal rats (P 
0.05); , significant difference between diabetic rats in different groups (P 
0.05).
FIG 4 Diabetes increases the TNF- expression in the gingival epithelia of A.
actinomycetemcomitans-infected rats. TNF--positive cells were detected by
immunohistochemistry in histologic specimens using a specific antibody. The
rats described in Fig. 1 were examined for TNF- expression using the follow-
ing scale that took both the number of immunopositive cells and the intensity
of the immunostaining into account: 0, no positive cells; 1, three to four pos-
itive cells per field with weak immunostaining; 2, four to ten positive cells per
field with strong immunostaining; and 3, more than ten positive cells per field
with strong immunostaining. (A) TNF- expression in the gingival epithelia of
diabetic rats. (B) TNF- expression in noninfected (baseline) and infected (4
to 6 weeks) gingival epithelia in normoglycemic and diabetic rats. (C) Effect of
antibiotic treatment in normoglycemic and diabetic rats. Each value represents
the mean of 5 to 7 rats 	 the SEM. *, significant difference between diabetic
and normal rats (P  0.05); , significant difference between diabetic or
normal rats in different groups (P  0.05).
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Induction of apoptosis. Because apoptosis is thought to play
an important role in periodontal disease progression, we sought to
determine whether diabetic animals had significantly higher levels
of apoptosis in the gingival epithelium (see Fig. S4 in the supple-
mental material) and whether the increase was mediated by
caspase-3 in both. Prior to A. actinomycetemcomitans infection,
the level of apoptosis was low in both diabetic and normoglycemic
groups. The onset of A. actinomycetemcomitans infection signifi-
cantly increased the level of apoptosis 2- to 3-fold in the nor-
moglycemic rats and 12-fold in the diabetic rats, with the differ-
ence between the two groups being significant (P  0.05) (Fig.
6A). The results were similar when presented as the percentage of
gingival epithelial cells that were apoptotic or the number of apop-
totic epithelial cells/m2 (Fig. 6B). The principal leukocytic cell
type infiltrating A. actinomycetemcomitans-infected gingiva was
the granulocyte. Apoptosis was evaluated as the percentage of
FIG 5 TNF- expression is increased in gingival connective tissues of diabetic rats following A. actinomycetemcomitans infection. (A) TNF- expression in
gingival connective tissues of diabetic rats. (B) TNF- expression in noninfected (baseline) and infected (4 – 6 weeks) gingival connective tissues in normogly-
cemic and diabetic rats. (C) Effect of antibiotic treatment in gingival connective tissues of normoglycemic and diabetic rats. Each value represents the mean of
five to seven rats 	 the SEM. *, significant difference between diabetic and normal rats (P  0.05); , significant difference between diabetic or normal rats in
different groups (P  0.05).
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nonleukocytic TUNEL CD18 cells in the gingival epithelium.
The number of TUNEL CD18 epithelial cells was significantly
increased in both the normal and diabetic groups after A. actino-
mycetemcomitans infection (P  0.05) (Fig. 6C). The percentage
of apoptotic cells in diabetic animals was 2-fold greater than in
normoglycemic animals (P  0.05) (Fig. 6C). To assess the impact
of inhibiting caspase-3/7, the specific caspase inhibitor DEVD was
administered daily, starting at week 4, and the number of
TUNEL CD18 cells was counted 1 week later. A. actinomyce-
temcomitans infection at this time point increased the apoptosis of
epithelial cells by 2.6-fold compared to the baseline, but antibiotic
treatment had no significant effect in reducing these levels (P 

0.05). Treatment with caspase inhibitor plus antibiotics reduced
the number of apoptotic epithelial cells by reversing the impact of
A. actinomycetemcomitans infection to baseline levels (P  0.05)
(Fig. 6D).
Apoptosis was also examined in gingival connective tissue.
Both normal and diabetic rats showed an almost 3-fold increase in
apoptotic cells after infection when examined as the percentage of
positive cells or as the number of apoptotic cells per area (P 
0.05) (Fig. 7A and B). The total numbers of apoptotic cells in the
gingival connective tissue of the diabetic group were 
2-fold
higher than for the normoglycemic rats (P  0.05). The percent-
age of TUNEL CD18 cells in the gingival connective tissue was
measured. After A. actinomycetemcomitans infection, the values
increased 3.9-fold (P  0.05) in diabetic animals but not in nor-
mal animals (Fig. 7C). At 5 weeks after A. actinomycetemcomitans
infection, the percentage of TUNEL CD18 cells significantly
increased in the diabetic group (P  0.05) (Fig. 7D). Antibiotic
treatment alone had no effect, but antibiotic treatment combined
with caspase-3/7 inhibitor significantly blocked the increase in
nongranulocytic cell apoptosis in the connective tissue (P  0.05)
(Fig. 7D).
DISCUSSION
The results presented here demonstrate that A. actinomycetem-
comitans infection significantly enhances PMN infiltration and
TNF- expression in both normal and diabetic rats. Moreover,
each of these parameters was significantly greater in the diabetic
animals, a finding which agrees with the increased bone loss ob-
served in the diabetic group here as well as in other studies (17, 29,
30). Thus, diabetic rats exhibited greater inflammatory responses
compared to the normoglycemic group in response to similar A.
actinomycetemcomitans inocula.
Diabetes generally enhances inflammation by altering myeloid
and lymphoid functions (12, 34). We found here that the local
periodontal inflammatory response in diabetic animals was
greater, as evidenced by an enhanced expression of TNF- and a
larger PMN infiltrate, and this finding is consistent with findings
in other models (15, 33). These local findings were in agreement
FIG 6 Diabetes increases the apoptosis of epithelial cells of A. actinomycetemcomitans-infected rats in a caspase-3-dependent manner. Apoptotic cells were
detected in gingival epithelium by TUNEL staining in the epithelia in the rats described in Fig. 1. In some groups, rats were treated with antibiotic or antibiotic
plus capase-3 inhibitor starting at week 4. (A) Percentage of apoptotic gingival epithelial cells per total number of gingival epithelial cells; (B) total number of
apoptotic gingival epithelial cells per area. (C and D) Nonleukocytic cells were identified as CD18 negative, and apoptotic cells were identified as TUNEL positive.
(C) TUNEL CD18 cells per total number of CD18 cells. (D) Rats at week 4 were treated with antibiotic or antibiotic plus caspase-3 inhibitor and euthanized
a week later. The TUNEL CD18 cells per total number of CD18 cells were counted. Each value is the mean of five to seven rats 	 the SEM. *, significant
difference between diabetic and normal rats (P  0.05); , significant difference between diabetic or normal rats in different groups (P  0.05); ^, significant
difference between antibiotic and antibiotic plus caspase-3 inhibitor.
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with the significant increase in the percentage of whole-blood
granulocytes in diabetic rats postinfection. Elevated levels of anti-
body against A. actinomycetemcomitans were also found in dia-
betic rats postinfection compared to normal rats. The number of
lymphocytes collected from whole blood, however, did not exhibit
the same trend, showing a significant decrease compared to nor-
moglycemic rats after A. actinomycetemcomitans infection. It is
conceivable that this decrease in lymphocyte population could be
a result of CDT-induced apoptosis. Alternatively, the decrease in
lymphocyte population after A. actinomycetemcomitans infection
may be due to a proportional increase in granulocytes.
A. actinomycetemcomitans infection has been shown to in-
crease apoptosis in vitro but has not yet been tested in vivo in a
periodontal model (20). We demonstrate here that inoculating
animals with A. actinomycetemcomitans significantly stimulated
apoptosis in both the gingival epithelium and connective tissue of
rats, especially in diabetic animals. Other studies have also shown
that apoptosis is significantly increased in diabetes when peri-
odontal disease is induced in an animal model (14, 29). There are
several mechanisms through which A. actinomycetemcomitans in-
fection could enhance apoptosis in the rat. Our study indicates
that the high rate of apoptosis in diabetic rats due to A. actinomy-
cetemcomitans infection is largely blocked by a caspase-3/7 inhib-
itor. It is possible that A. actinomycetemcomitans through its cyto-
lethal distending toxin (CDT) could stimulate apoptosis. CDT has
been shown to induce apoptosis in epithelial cells, fibroblasts, and
endothelial cells (19, 35). It has recently been shown that CDT
induces apoptosis through a caspase-3-dependent pathway in im-
mortalized gingival epithelial cells (1). However, the other apop-
tosis-inducing factor produced by A. actinomycetemcomitans, leu-
kotoxin A, appears not to stimulate apoptosis in rat cells (20).
Alternatively, A. actinomycetemcomitans could induce apoptosis
through indirect mechanisms. Interestingly, diabetic rats had sig-
nificantly higher TNF- levels and more apoptotic cells compared
to normal rats after A. actinomycetemcomitans infection. TNF-
has been shown to mediate both P. gingivalis- and lipopolysaccha-
ride-induced apoptosis in vivo (2, 11). Thus, excessive production
of TNF- is another potential pathway through which diabetes
could enhance the apoptosis of epithelial and connective tissue
cells, thereby affecting the response to bacterial infection, and may
occur simultaneously with CDT-induced apoptosis.
The impact of antibiotic treatment postinfection was also eval-
uated. Antibiotics have long been used as an adjunct therapy in the
treatment of localized aggressive periodontitis (18, 41, 42). We
also examined the impact of antibiotic treatment on A. actinomy-
cetemcomitans antibody titer, alveolar bone resorption, PMN in-
filtration, TNF- levels, and apoptosis in A. actinomycetemcomi-
tans-infected periodontium. For A. actinomycetemcomitans
antibody titer, PMN infiltration, TNF- levels, and apoptosis, the
diabetic rats showed a significant reduction with antibiotic treat-
ment, whereas these parameters were not reduced by antibiotic
treatment in normoglycemic rats. These results suggest that there
are antibacterial deficits in diabetic animals that contribute to
greater induction of proinflammatory events stimulated by peri-
FIG 7 Diabetes increases apoptosis of cells in gingival connective tissue of A. actinomycetemcomitans-infected rats in a caspase-3-dependent manner. (A) Total
apoptotic gingival connective tissue cells per total number of gingival connective tissue cells. (B) Total apoptotic gingival connective tissue cells per epithelial area.
(C and D) Nonleukocytic cells were identified as CD18 negative, and apoptotic cells were identified as TUNEL positive. (C) TUNEL CD18 cells per total
number of CD18 cells in connective tissue. (D) Rats at week 4 were treated with antibiotic or antibiotic and caspase-3 inhibitor and euthanized a week later. The
TUNEL CD18 cells per total number of CD18 cells were counted. Each value is the mean of five to seven rats 	 the SEM. *, significant difference between
diabetics and normal rats (P  0.05); , significant difference between diabetics or normal rats in different groups (P  0.05); ^, significantly different between
antibiotic and antibiotic plus caspase-3 inhibitor.
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odontal pathogens at the local level that can be reversed by anti-
biotic treatment.
In summary, the impact of diabetes on the periodontium was
investigated in a relatively new model of periodontitis, oral inoc-
ulation of A. actinomycetemcomitans in the rat, which has the ad-
vantage that the rat is a natural host of A. actinomycetemcomitans.
In this model, diabetes affected A. actinomycetemcomitans-in-
duced periodontal destruction by significantly increasing the in-
flammatory response, leading to increased bone loss and apopto-
sis of gingival epithelial and connective tissue cells. The excessive
production of TNF- and the impact of CDT could be potential
mechanisms through which apoptosis was induced at higher levels
in diabetic animals. Antibiotics were able to reverse many param-
eters of the local host response in diabetic animals compared to
normoglycemic animals, suggesting that a component to the en-
hanced inflammatory response is due to a deficit in the capacity of
diabetic animals to resist infection. This information provides
valuable insight as to how diabetes may alter host-bacterium in-
teractions in a way that promotes periodontal breakdown.
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